HIV

Variation seen in number of cancer survivors undergoing HIV testing

Variation seen in number of cancer survivors undergoing HIV testing

Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.

Only 41% of cancer survivors tested for HIV

Only 41% of cancer survivors tested for HIV

Only 41% of cancer survivors in the U.S. under 65 reported ever having a human immunodeficiency virus (HIV) test.

Steroids used for HIV-associated tuberculosis increase cancer risk

Steroids used for HIV-associated tuberculosis increase cancer risk

Adding steroids for the treatment of tuberculosis pericarditis in patients co-infected with HIV may increase the risk of cancer.

HIV-positive patients are more likely to be untreated for early-stage cancer

By

HIV-infected people with early stage cancer are two to four times more likely to go untreated for their cancer compared to uninfected patients with cancer, according to a new, large retrospective study.

Those with HIV less likely to receive cancer treatment

Those with HIV less likely to receive cancer treatment

HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.

Potential treatment for deadly HIV-related blood cancer

By

Researchers have discovered a promising new way to treat a rare and aggressive blood cancer that is most commonly found in people infected with HIV.

Incidence of nonmelanoma skin cancers two-fold higher for HIV-positive patients

By

HIV-positive patients have a higher incidence of nonmelanoma skin cancers. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive persons.

Fewer than one-third of U.S. teen girls vaccinated for HPV

Fewer than one-third of U.S. teen girls vaccinated for HPV

In 2010, 32 percent had received three doses of vaccine; incidence of some HPV-linked cancers up.

Despite cART, anal cancer risk still high for HIV-infected

Despite cART, anal cancer risk still high for HIV-infected

High incidence compared to general population, especially for men who have sex with men.

Public health initiatives for head and neck cancers

Public health initiatives for head and neck cancers

By

Based on the current literature associating human papillomavirus (HPV) with head and neck cancer, what public health initiatives need to be implemented?

Preexposure chemoprophylaxis cuts HIV infection at a cost

Preexposure chemoprophylaxis cuts HIV infection at a cost

Targeted prophylaxis strategy is most cost-effective in highest risk men who have sex with men.

Bevacizumab Active in HIV-Linked Kaposi's Sarcoma

Bevacizumab Active in HIV-Linked Kaposi's Sarcoma

Phase 2 study shows overall response rate of 31 percent in patients with poor-prognosis HIV-KS.

Antiretroviral Medications Linked to Cleft Deformities

Antiretroviral Medications Linked to Cleft Deformities

Drugs to keep HIV-infected women from transmitting virus to fetus may trigger cleft defects.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs